Valuation Tenax Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 00:00:00 04/09/2026 +04			5-day change	1st Jan Change
1.780 ^USD	-3.78%		-18.72%	-85.40%

08-31	Guggenheim Downgrades Tenax Therapeutics to Neutral From Buy	MT
08-29	Tenax Therapeutics Presents Additional Results from Phase 3 Level Clinical Trial Evaluating Tnx-103 in Patients with Pulmonary Hypertension Due to Heart Failure with Preserved Ejection Fraction	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	26.21	4.979	6.553	218.5	494.6	102	-	-
Change	-	-81.01%	31.6%	3,233.86%	126.39%	-79.38%	-	-
Enterprise Value (EV) ¹	26.21	4.979	6.553	218.5	494.6	16.76	91.76	102
Change	-	-81.01%	31.6%	3,233.86%	126.39%	-96.61%	447.44%	11.12%
P/E	-0.66x	-0.3x	-0.71x	-5.38x	-9.1x	-1.23x	-1.19x	-1.11x
PBR	-	-	-	-	-	-	-	-
PEG	-	0x	0x	0.1x	-0.6x	-0.15x	-0.36x	-0.15x
Capitalization / Revenue	-	-	-	-	-	-	-	8.5x
EV / Revenue	-	-	-	-	-	-	-	8.5x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0.8x	-0.45x	-0.8x	-11.2x	-8.77x	-0.22x	-1.05x	-0.97x
EV / FCF	-	-	-	-	-	-0.34x	-1.06x	-0.79x
FCF Yield	-	-	-	-	-	-298%	-94.3%	-126%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-2,528	-600.8	-31.04	-1.15	-1.34	-1.452	-1.5	-1.608
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	-	-	-	-	-	-	12
EBITDA	-	-	-	-	-	-	-	-
EBIT ¹	-32.73	-11.05	-8.234	-19.49	-56.38	-75.97	-87.2	-104.9
Net income ¹	-32.47	-11.05	-7.711	-17.6	-52.6	-72.73	-84.06	-99.54
Net Debt ¹	-	-	-	-	-	-85.2	-10.2	-
Reference price ²	1,664.000	178.238	21.968	6.190	12.190	1.780	1.780	1.780
Nbr of stocks (in thousands)	15.8	27.9	298	35,292	40,570	57,282	-	-
Announcement Date	29/03/22	31/03/23	28/03/24	25/03/25	10/03/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
TENAX THERAPEUTICS, INC.	-1.23x	-	-	-	102M
LONZA GROUP AG	33.99x	6.09x	18.25x	0.94%	50.35B
REVOLUTION MEDICINES, INC.	-21.55x	255.32x	-23.29x	-.--%	45.2B
IQVIA HOLDINGS INC.	34.98x	3.36x	14.51x	-.--%	44.71B
BEONE MEDICINES AG	47.51x	5.49x	30.13x	-.--%	41.24B
CELLTRION, INC.	28.36x	8.58x	21.72x	0.41%	33.08B
MEDPACE HOLDINGS, INC.	33.74x	5.53x	25.11x	-.--%	16.56B
EUROFINS SCIENTIFIC SE	24.49x	2.12x	9.19x	1.1%	14.82B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	78.47x	4.12x	15.98x	-.--%	14B
Average	28.75x	36.33x	13.95x	0.31%	28.9B
Weighted average by Cap.	27.76x	48.81x	12.51x	0.3%